Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13G Filing: Rosalind Advisors, Inc. and Zosano Pharma Corp (NASDAQ:ZSAN)

Page 1 of 9

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Rosalind Advisors, Inc 0 2,083,100 0 2,083,100 2,083,100 5.5%
Steven Salamon 0 2,083,100 0 2,083,100 2,083,100 5.5%
Rosalind Master Fund 0 584,761 0 584,761 584,761 1.6%
Rosalind Capital Partners 0 1,498,339 0 1,498,339 1,498,339 4.0%

Page 1 of 9 – SEC Filing

UNITED
STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE
13G/A

(Amendment
No. 1) 

Under
the Securities Exchange Act of 1934

ZOSANO PHARMA
CORPORATION

(Name
of Issuer)

Common Shares

(Title
of Class of Securities)

98979H103

(CUSIP
Number)

March 28, 2017

(Date
of Event which Requires Filing of this Statement)

Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:

o Rule 13d-1(b)
x Rule 13d-1(c)
o Rule 13d-1(d)

*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in
a prior cover page.

The information
required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the Notes).

Follow Zosano Pharma Corp (NASDAQ:ZSAN)
Trade (NASDAQ:ZSAN) Now!
Page 1 of 9